These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17697443)

  • 21. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
    Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
    Poulakou G; Katsarolis I; Matthaiopoulou I; Tsiodras S; Kanavaki S; Hatzaki D; Roilides E; Sofianou D; Kavaliotis I; Kansouzidou A; Kafetzis DA; Paraskakis I; Foustoukou M; Daikos GL; Syriopoulou V; Pangalis A; Leveidiotou S; Giamarellou H;
    Int J Antimicrob Agents; 2007 Jul; 30(1):87-92. PubMed ID: 17540542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.
    Siira L; Rantala M; Jalava J; Hakanen AJ; Huovinen P; Kaijalainen T; Lyytikäinen O; Virolainen A
    Antimicrob Agents Chemother; 2009 May; 53(5):2066-73. PubMed ID: 19273677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.
    Guevara S; Abdelnour A; Soley C; Porat N; Dagan R; Arguedas A
    Vaccine; 2012 Jun; 30(26):3857-61. PubMed ID: 22521846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe.
    Bruinsma N; Kristinsson KG; Bronzwaer S; Schrijnemakers P; Degener J; Tiemersma E; Hryniewicz W; Monen J; Grundmann H;
    J Antimicrob Chemother; 2004 Dec; 54(6):1045-50. PubMed ID: 15531598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive erythromycin-resistant pneumococcal isolates are more often non-susceptible to more antimicrobial agents than invasive isolates.
    Lambertsen LM; Harboe ZB; Konradsen HB; Christensen JJ; Hammerum AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):72-5. PubMed ID: 19892529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009.
    Ho PL; Chiu SS; Ang I; Lau YL
    Vaccine; 2011 Apr; 29(17):3270-5. PubMed ID: 21352937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage.
    Rolo D; Fenoll A; Ardanuy C; Calatayud L; Cubero M; de la Campa AG; Liñares J
    J Antimicrob Chemother; 2011 Aug; 66(8):1712-8. PubMed ID: 21628304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chan MY; Ang I; Chow KH; Lau YL
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):327-34. PubMed ID: 22000087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14.
    Dias R; Caniça M
    J Antimicrob Chemother; 2004 Dec; 54(6):1035-9. PubMed ID: 15531597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive pneumococci before the introduction of pneumococcal conjugate vaccine in Turkey: antimicrobial susceptibility, serotype distribution, and molecular identification of macrolide resistance.
    Altun HU; Hascelik G; Gür D; Eser ÖK
    J Chemother; 2015 Feb; 27(2):74-9. PubMed ID: 24548097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in numbers of beta-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage.
    Brandileone MC; Casagrande ST; Guerra MLS; Zanella RC; Andrade ASS; Fabio JD
    J Med Microbiol; 2006 May; 55(Pt 5):567-574. PubMed ID: 16585644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.
    Tyrrell GJ; Lovgren M; Chui N; Minion J; Garg S; Kellner JD; Marrie TJ
    Vaccine; 2009 Jun; 27(27):3553-60. PubMed ID: 19464534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype and antimicrobial profile distribution of invasive pneumococcal isolates in the pre-vaccine introduction era in Pretoria, South Africa, 2005 through 2009.
    Silberbauer EJ; Ismail N; von Gottberg A; Hoosen AA
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):309-11. PubMed ID: 21907527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.
    Aguiar SI; Brito MJ; Gonçalo-Marques J; Melo-Cristino J; Ramirez M
    Vaccine; 2010 Jul; 28(32):5167-73. PubMed ID: 20558247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region.
    Borg MA; Tiemersma E; Scicluna E; van de Sande-Bruinsma N; de Kraker M; Monen J; Grundmann H;
    Clin Microbiol Infect; 2009 Mar; 15(3):232-7. PubMed ID: 19154490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.